84-1052-64 Factor VII (F.VII, Stable Factor, Proconvertin) (HRP) 200ug F0015-20B

※お見積書はカートで印刷できます

冷凍

特徴

  • Factor VII (F.VII) is a vitamin K-dependent glycoprotein produced in the liver.
  • Plasma concentration of F.VII is normally ~0.5ug/ml (10nM) in plasma.
  • A deficiency of F.VII is associated with bleeding in a clinical pattern similar to haemo- philia, but is inherited as an autosomal recessive trait.
  • The deficiency can be characterized by a quantitative (low activity and low antigen) or a qualitative (low activity and normal antigen) defect in F.VII function.
  • In its zymogen form F.VII is a single chain molecule of ~50kD.
  • It contains two EGF-like domains and an amino-terminal domain containing 10 gamma-carboxyglutamic acid (Gla) residues.
  • These Gla residues allow F.VII to bind divalent metal ions and participate in calcium-dependent binding interactions.
  • F.VII and activated F.VII (F.VIIa) bind to tissue factor exposed at the site of vascular injury.
  • F.IXa, F.Xa or F.VIIa rapidly activate tissue factor-bound F.VII to F.VIIa in the presence of calcium and phospholipid.
  • Thrombin and F.XIIa are able to activate F.VII in the fluid phase in the absence of cofactors.
  • The activation of the single chain zymogen F.VII occurs by proteolysis after residue Arg152, resulting in a two-chain active serine protease consisting of a 30kD heavy chain and an 18kD light chain.
  • In complex with tissue factor, phospholipid and calcium, F.VIIa is able to activate F.X and F.IX.
  • Free F.VIIa in plasma is remarkably stable, but the activity of F.VIIa/TF complex is regulated by Tissue Factor Pathway Inhibitor (TFPI) in the presence of F.Xa, and also by Antithrombin (ATIII) in the presence of heparin.
  • Applications:Suitable for use in ELISA and Immunoelectrophoresis.
  • Other applications not tested.
  • Recommended Dilutions:Optimal dilutions to be determined by the researcher.
  • Rz Ratio (Reinheitszahl A403/A280):0.5
  • Storage and Stability:Store product at 4°C if to be used immediately within two weeks.
  • For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20°C.
  • Aliquots are stable at -20°C for 12 months after receipt.
  • Dilute required amount only prior to immediate use.
  • Further dilutions can be made in assay buffer.
  • Note: Sodium azide is a potent inhibitor of peroxidase and should not be added to HRP conjugates.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:200ug
  • Host:sheep
  • Source Antibody:human
  • Grade:Purified
  • Purity:Purified.
  • Form:Supplied as a liquid in a stabilizer protein solution, 50% glycerol. Labeled with Horseradish peroxidase (HRP).
  • Specificity:Recognizes human Factor VII. No reaction was observed against Factor VII-deficient plasma by immunoelectrophoresis.
  • Isotype:IgG
  • Calc Applications Abbrev:E
  • Calc Crossreactivity:Hu
  • Immunogen:Human Factor VII purified from plasma.
  • Shelf Life:1year
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1052-64
型番
F0015-20B
入り数
1個
標準価格
176,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る